Split-CreERT2: Temporal Control of DNA recombination mediated by split-cre protein Fragment Complementation

PLoS ONE

Volumn 4, Issue 12, 2009, Pages

  Hirrlinger, Johannes ^a,b   Requardt, Robert P ^a   Winkler, Ulrike ^a   Wilhelm, Franziska ^a   Schulze, Christine ^a   Hirrlinger, Petra G ^b  

^a UNIVERSITY HOSPITAL LEIPZIG   (Germany)

^b UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROXYTAMOXIFEN; CRE RECOMBINASE; ESTRADIOL RECEPTOR; ESTRADIOL RECEPTOR 2; HYBRID PROTEIN; TAMOXIFEN; UNCLASSIFIED DRUG; DNA; INTEGRASE; LUCIFERASE;

ARTICLE; CHO CELL; CONTROLLED STUDY; DNA RECOMBINATION; GENE CASSETTE; GENE CONSTRUCT; GENETIC COMPLEMENTATION; GENETIC REGULATION; IMMUNOCYTOCHEMISTRY; IN VITRO STUDY; LOXP SITE; PROMOTER REGION; REPORTER GENE; WESTERN BLOTTING; ANIMAL; CELL STRAIN; CHEMISTRY; CRICETULUS; ENZYME ASSAY; FLOW CYTOMETRY; GENETIC ENGINEERING; GENETIC RECOMBINATION; GENETICS; HAMSTER; HUMAN; IMMUNOHISTOCHEMISTRY; METABOLISM; METHODOLOGY; MOUSE; PROTEIN TERTIARY STRUCTURE; RAT; TIME;

MUS;

ANIMALS; BLOTTING, WESTERN; CHO CELLS; CRICETINAE; CRICETULUS; DNA; ENZYME ASSAYS; FLOW CYTOMETRY; GENETIC ENGINEERING; HUMANS; IMMUNOHISTOCHEMISTRY; INTEGRASES; LUCIFERASES; MICE; PC12 CELLS; PROTEIN STRUCTURE, TERTIARY; RATS; RECEPTORS, ESTRADIOL; RECOMBINATION, GENETIC; TIME FACTORS;

EID: 77949532370     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0008354     Document Type: Article

References (35)

1. Branda CS, Dymecki SM (2004) Talking about a revolution: The impact of site- specific recombinases on genetic analyses in mice. Dev Cell 6: 7-28.
2. Bockamp E, Sprengel R, Eshkind L, Lehmann T, Braun JM, et al. (2008) Conditional transgenic mouse models: from the basics to genome-wide sets of knockouts and current studies of tissue regeneration. Regen Med 3: 217-235.
3. Nagy A (2000) Cre recombinase: the universal reagent for genome tailoring. Genesis 26: 99-109.
4. Lewandoski M (2001) Conditional control of gene expression in the mouse. Nat Rev Genet 2: 743-755.
5. Lakso M, Sauer B, Mosinger B Jr, Lee EJ, Manning RW, et al. (1992) Targeted oncogene activation by site-specific recombination in transgenic mice. Proc Natl Acad Sci U S A 89: 6232-6236.
6. Orban PC, Chui D, Marth JD (1992) Tissue- and site-specific DNA recombination in transgenic mice. Proc Natl Acad Sci U S A 89: 6861-6865.
7. Malatesta P, Hack MA, Hartfuss E, Kettenmann H, Klinkert W, et al. (2003) Neuronal or glial progeny: regional differences in radial glia fate. Neuron 37: 751-764.
8. Casper KB, McCarthy KD (2006) GFAP-positive progenitor cells produce neurons and oligodendrocytes throughout the CNS. Mol Cell Neurosci.
9. Delaunay D, Heydon K, Cumano A, Schwab MH, Thomas JL, et al. (2008) Early neuronal and glial fate restriction of embryonic neural stem cells. J Neurosci 28: 2551-2562.
10. Young KM, Fogarty M, Kessaris N, Richardson WD (2007) Subventricular zone stem cells are heterogeneous with respect to their embryonic origins and neurogenic fates in the adult olfactory bulb. J Neurosci 27: 8286-8296.
11. Buch T, Heppner FL, Tertilt C, Heinen TJ, Kremer M, et al. (2005) A Cre- inducible diphtheria toxin receptor mediates cell lineage ablation after toxin administration. Nat Methods 2: 419-426.
12. Brockschnieder D, Lappe-Siefke C, Goebbels S, Boesl MR, Nave KA, et al. (2004) Cell depletion due to diphtheria toxin fragment A after Cre-mediated recombination. Mol Cell Biol 24: 7636-7642.
13. Feil R, Wagner J, Metzger D, Chambon P (1997) Regulation of Cre recombinase activity by mutated estrogen receptor ligand-binding domains. Biochem Biophys Res Commun 237: 752-757.
14. Luo L, Callaway EM, Svoboda K (2008) Genetic dissection of neural circuits. Neuron 57: 634-660.
15. Hirrlinger J, Scheller A, Hirrlinger PG, Kellert B, Tang W, et al. (2009) Split-cre complementation indicates coincident activity of different genes in vivo. PLoS ONE 4: e4286.
16. Wehr MC, Laage R, Bolz U, Fischer TM, Grunewald S, et al. (2006) Monitoring regulated protein-protein interactions using split TEV. Nat Methods 3: 985-993.
17. Hameyer D, Loonstra A, Eshkind L, Schmitt S, Antunes C, et al. (2007) Toxicity of ligand-dependent Cre recombinases and generation of a conditional Cre deleter mouse allowing mosaic recombination in peripheral tissues. Physiol Genomics 31: 32-41.
18. Weber P, Metzger D, Chambon P (2001) Temporally controlled targeted somatic mutagenesis in the mouse brain. Eur J Neurosci 14: 1777-1783.
19. Zhu HZ, Chen JQ, Cheng GX, Xue JL (2003) Generation and characterization of transgenic mice expressing tamoxifen-inducible cre-fusion protein specifically in mouse liver. World J Gastroenterol 9: 1844-1847.
20. Brocard J, Warot X, Wendling O, Messaddeq N, Vonesch JL, et al. (1997) Spatio-temporally controlled site-specific somatic mutagenesis in the mouse. Proc Natl Acad Sci U S A 94: 14559-14563.
21. Feil R, Brocard J, Mascrez B, LeMeur M, Metzger D, et al. (1996) Ligand- activated site-specific recombination in mice. Proc Natl Acad Sci U S A 93: 10887-10890.
22. Indra AK, Warot X, Brocard J, Bornert JM, Xiao JH, et al. (1999) Temporally- controlled site-specific mutagenesis in the basal layer of the epidermis: comparison of the recombinase activity of the tamoxifen-inducible Cre-ER(T) and Cre-ER(T2) recombinases. Nucleic Acids Res 27: 4324-4327.
23. Hirrlinger PG, Scheller A, Braun C, Hirrlinger J, Kirchhoff F (2006) Temporal control of gene recombination in astrocytes by transgenic expression of the tamoxifen-inducible DNA recombinase variant CreERT2. Glia 54: 11-20.
24. Erdmann G, Schutz G, Berger S (2007) Inducible gene inactivation in neurons of the adult mouse forebrain. BMC Neurosci 8: 63.
25. Mori T, Tanaka K, Buffo A, Wurst W, Kuhn R, et al. (2006) Inducible gene deletion in astroglia and radial glia-a valuable tool for functional and lineage analysis. Glia 54: 21-34.
26. Doring B, Shynlova O, Tsui P, Eckardt D, Janssen-Bienhold U, et al. (2006) Ablation of connexin43 in uterine smooth muscle cells of the mouse causes delayed parturition. J Cell Sci 119: 1715-1722.
27. Leone DP, Genoud S, Atanasoski S, Grausenburger R, Berger P, et al. (2003) Tamoxifen-inducible glia-specific Cre mice for somatic mutagenesis in oligodendrocytes and Schwann cells. Mol Cell Neurosci 22: 430-440.
28. Slezak M, Goritz C, Niemiec A, Frisen J, Chambon P, et al. (2007) Transgenic mice for conditional gene manipulation in astroglial cells. Glia 55: 1565-1576.
29. Nagy A, Mar L, Watts G (2009) Creation and use of a cre recombinase transgenic database. Methods Mol Biol 530: 365-378.
30. Jullien N, Sampieri F, Enjalbert A, Herman JP (2003) Regulation of Cre recombinase by ligand-induced complementation of inactive fragments. Nucleic Acids Res 31: e131.
31. Jullien N, Goddard I, Selmi-Ruby S, Fina JL, Cremer H, et al. (2007) Conditional transgenesis using Dimerizable Cre (DiCre). PLoS ONE 2: e1355.
32. Dymecki SM, Kim JC (2007) Molecular neuroanatomy's ''Three Gs'': a primer. Neuron 54: 17-34.
33. Csaba G, Karabelyos C (2001) The effect of a single neonatal treatment (hormonal imprinting) with the antihormones, tamoxifen and mifepristone on the sexual behavior of adult rats. Pharmacol Res 43: 531-534.
34. Vancutsem PM, Roessler ML (1997) Neonatal treatment with tamoxifen causes immediate alterations of the sexually dimorphic nucleus of the preoptic area and medial preoptic area in male rats. Teratology 56: 220-228.
35. Mandlekar S, Kong AN (2001) Mechanisms of tamoxifen-induced apoptosis. Apoptosis 6: 469-477.